Keyphrases
Bare Metal Stent
60%
Coronary Artery Disease
58%
Myocardial Flow Reserve
50%
Chronic Coronary Syndrome
49%
Diagnostic Test
45%
Angina
35%
Pre-test Probability
35%
Large Coronary Artery
33%
Positron Emission Tomography
32%
Myocardial Perfusion Imaging
30%
Small Vessel Disease
30%
Ultra-thin Strut
30%
Passive Coating
30%
Prediction Model
30%
82Rb-PET
30%
Prognostic Marker
30%
All-cause Mortality
30%
PET Myocardial Perfusion Imaging
30%
Rubidium
30%
Coronary Microvascular Disease
30%
Kidney
30%
Gatekeepers
30%
Rule-out Test
30%
Cost-effectiveness
30%
Large Coronary
30%
Prospective Randomized Trial
30%
Pooled Analysis
30%
Acoustics
30%
Drug-eluting Stent
30%
Stent
30%
Patient Assessment
30%
Coronary Vessels
30%
CoCr
30%
Cobalt-chromium Alloy
30%
Silicon Carbide
25%
Perfusion Defect
23%
Adverse Cardiac Events
17%
European Society of Cardiology
16%
Cardiac Death
16%
Disease Score
15%
Safety Endpoints
15%
Nonfatal Myocardial Infarction
13%
Event Rate
12%
Left Ventricular Ejection Fraction
12%
Estimated Glomerular Filtration Rate
10%
Microvascular Events
10%
BMS Group
10%
Disease Prevalence
10%
Thin Struts
10%
Stent Thrombosis
10%
Medicine and Dentistry
Coronary Artery Disease
100%
Heart Muscle Ischemia
60%
Myocardial Perfusion Imaging
60%
Rubidium 82
60%
Diagnosis
60%
Coronary Circulation
50%
Angina pectoris
38%
Coronary Artery
33%
Symptom
33%
Positron Emission Tomography
32%
Silicon Carbide
30%
Drug-Eluting Stent
30%
Pooled Analysis
30%
All Cause Mortality
30%
Cost-Effectiveness Analysis
30%
Microangiopathy
30%
Small Vessel Disease
30%
Positron Emission Tomography
30%
Coronary Vessel
30%
Major Adverse Cardiac Event
24%
Myocardial Infarction
23%
Diagnostic Test
21%
Cardiology
20%
Heart Death
15%
Stenting
15%
Hazard Ratio
14%
Heart Left Ventricle Ejection Fraction
12%
Stent Thrombosis
12%
Revascularization
11%
Glomerular Filtration Rate
10%
Prevalence
10%
Target Vessel Revascularization
9%
Cumulative Incidence
9%
Outpatient
8%
Quality of Life
8%
Proportional Hazards Model
6%
Thrombogenicity
6%
Restenosis
6%
Antiplatelet
6%
Cohort Analysis
5%
Vascular Disease
5%
Apoplexy
5%
Chronic Kidney Disease
5%
Nephropathy
5%
Diabetes
5%
